Martin Shkreli, the pharmaceutical entrepreneur vilified as the “pharma bro” for raising the price of a life-saving drug by 5,000 percent, said on Monday in federal court that he would not testify in his securities fraud trial.
Shkreli’s statement to U.S. District Judge Kiyo Matsumoto came after jurors had been dismissed for the day in the middle of testimony from U.S. prosecutors’ last witness in the case, a Federal Bureau of Investigation agent who investigated Shkreli.
Prosecutors could rest their case as early as Tuesday, and closing arguments could come by the end of the week. Jurors heard opening arguments on June 28.
Shkreli, 34, outraged patients and U.S. lawmakers by raising the price of the anti-infection drug Daraprim to $750 a pill, from $13.50, in 2015, when he was chief executive of Turing Pharmaceuticals.
The charges he now faces are not related to Turing but focus on Shkreli’s management of his previous drug company, Retrophin Inc, and of hedge funds MSMB Capital and MSMB Healthcare between 2009 and 2014.
Prosecutors have said Shkreli lied about MSMB’s finances to lure investors and concealed devastating trading losses from them. They said he paid the investors back with money and shares misappropriated from Retrophin, which he founded in 2011, using sham settlement and consulting agreements.
Shkreli has pleaded not guilty to securities fraud and conspiracy charges.
Shkreli has at times seemed to revel in his public infamy and since his December 2015 arrest, he has used social media to boast of his wealth and lash out at critics.
He was banned from Twitter in January for harassing a female journalist and has joined the social media platform under different names at least twice since then before being banned again.
On July 5, U.S. District Judge Kiyo Matsumoto ordered him not to talk about his case in or around the courthouse after he held an impromptu new conference days earlier.
(Reporting By Brendan Pierson in New York; Editing by Bill Trott)
Trump White House already scripting how impeachment trial will play out? WH counsel just walked into McConnell’s office
Just how much control will the Trump White House have over the Senate impeachment trial of President Donald Trump?
The White House Counsel, Pat Cipollone, just walked into Senate Majority Leader Mitch McConnell's office. Chances are good it wasn't for a friendly game of checkers.
And Cipollone was accompanied by Eric Ueland, a former member of the Trump transition team who Trump tried to hand a top State Dept. job to but was forced to pull his nomination. A recent promotion has elevated him to now serving as the White House Director of Legislative Affairs, after spending years working for then-Senator Jeff Sessions.
Matt Gaetz insists he wasn’t paying ‘much attention’ as he got burned during hearing – but video shows otherwise
Rep. Matt Gaetz (R-FL) lied when he was speaking to CNN's Manu Raju that he wasn't paying much attention when Rep. Hank Johnson (D-GA) explained that members with DUIs probably shouldn't be attacking someone for drug usage.
“I didn’t pay much attention to it ...I’m focused on the president .. I don’t think Americans are hanging on a traffic incident I had a decade ago,” Gaetz told Raju.
It wasn't factually accurate as videos show Gaetz paying quite a bit of attention and seemingly upset.
You can see the exchange in the video below:
White House ‘shamed into submission’: Senate finally passes Armenian genocide bill despite Trump’s objections
In a direct refutation of the repeated objections of the Trump administration this Thursday, the Senate unanimously passed a resolution recognizing the Armenian Genocide.
As USA Today points out, the historic move will likely complicate US-Turkey relations since it acknowledges that Turkey, then known as the Ottoman Empire, carried out the systematic killings of 1.5 million Armenians from 1915 to 1923.